Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031675
Filing Date
2024-08-13
Accepted
2024-08-13 17:03:54
Documents
55
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 979772
2 ex31-1.htm EX-31.1 9955
3 ex31-2.htm EX-31.2 9980
4 ex32-1.htm EX-32.1 4620
5 ex32-2.htm EX-32.2 4534
  Complete submission text file 0001493152-24-031675.txt   4558055

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE rnxt-20240630.xsd EX-101.SCH 31623
7 XBRL CALCULATION FILE rnxt-20240630_cal.xml EX-101.CAL 34506
8 XBRL DEFINITION FILE rnxt-20240630_def.xml EX-101.DEF 128472
9 XBRL LABEL FILE rnxt-20240630_lab.xml EX-101.LAB 291989
10 XBRL PRESENTATION FILE rnxt-20240630_pre.xml EX-101.PRE 224220
57 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 696433
Mailing Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110
Business Address 333 W. SANTA CLARA STREET, SUITE 900 SAN JOSE CA 95110 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40738 | Film No.: 241202756
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)